Nemera
Nemera, a leading global player in the pharmaceutical and medical device industry, is headquartered in France. Founded in 2004, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Specialising in the design and manufacturing of drug delivery systems, Nemera focuses on innovative solutions such as inhalers, injectors, and transdermal patches. With a commitment to enhancing patient experience, Nemera's core products are distinguished by their user-centric design and advanced technology. The company has achieved notable milestones, including strategic partnerships and a robust portfolio of intellectual property. Recognised for its expertise in the field, Nemera continues to solidify its market position as a trusted partner for pharmaceutical companies worldwide, driving advancements in drug delivery and patient care.
DitchCarbon Score
How does Nemera's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nemera's score of 48 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nemera's reported carbon emissions
In 2023, Nemera reported total carbon emissions of approximately 106,216,000 kg CO2e, comprising 1,290,680 kg CO2e from Scope 1, 76,400 kg CO2e from Scope 2, and about 104,848,500 kg CO2e from Scope 3 emissions. This data reflects a significant commitment to reducing greenhouse gas emissions across all scopes. Nemera has set ambitious targets to address its carbon footprint. The company aims to achieve a 90% reduction in absolute Scope 1 and Scope 2 greenhouse gas emissions by 2030, using 2019 as the baseline year. Additionally, Nemera is committed to reducing Scope 3 emissions from purchased goods and services by 55% per EUR value added within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit temperature rise to 1.5°C. Overall, Nemera's climate commitments demonstrate a proactive approach to sustainability within the healthcare equipment and supplies sector, reflecting its dedication to mitigating climate change impacts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 1,097,050 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 29,972,830 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000 |
| Scope 3 | 121,610,090 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nemera is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
